Biochemical experiments and integration analysis verified that the decreased HMOX2 and increased SERPINA3 could be hub molecules, show showed good consistency in the central and peripheral systems of AD patients and the AD transgenic mice, and was consistent with the proteomics results (Figures S4 and S5). This evidence concerns the gene HMOX2 and Alzheimer disease.